Robert Alexander
Chief Executive Officer bei ALLAKOS INC.
Vermögen: 2 Mio $ am 31.03.2024
Profil
Dr. Robert Alexander ist Chief Executive Officer & Director bei Allakos, Inc. und ein unabhängiger Director bei Allena Pharmaceuticals, Inc. Er ist Mitglied des Board of Directors von Allakos, Inc. und Allena Pharmaceuticals, Inc. Zuvor war Dr. Alexander als Chief Executive Officer & Director bei ZS Pharma, Inc. beschäftigt, als unabhängiger Director bei Lumena Pharmaceuticals, Inc, als Managing Partner bei TL Ventures LP, als Principal bei Genentech, Inc, als Principal bei MPM BioEquities Adviser LLC, als Principal bei MPM Capital Inc. und als Executive Chairman & Chief Executive Officer bei SARcode Bioscience, Inc. Außerdem war er Vorstandsmitglied bei Alta Partners Management Corp. und Sonexa Therapeutics, Inc. Er erhielt seinen Bachelor-Abschluss von der Miami University und einen Doktortitel von der University of North Carolina in Asheville.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
ALLAKOS, INC.
1,36% | 04.03.2024 | 1 194 076 ( 1,36% ) | 2 Mio $ | 31.03.2024 |
Aktive Positionen von Robert Alexander
| Unternehmen | Position | Beginn |
|---|---|---|
| ALLAKOS INC. | Chief Executive Officer | 01.04.2017 |
Ehemalige bekannte Positionen von Robert Alexander
| Unternehmen | Position | Ende |
|---|---|---|
| ALLENA PHARMACEUTICALS, INC. | Director/Board Member | 01.02.2022 |
| ZS PHARMA INC | Chief Executive Officer | 01.03.2017 |
SARcode Bioscience, Inc.
 SARcode Bioscience, Inc. Pharmaceuticals: MajorHealth Technology SARcode Bioscience, Inc., develops biopharmaceutical products. Its program is a novel class of lymphocyte function-associated antigen-1 (LFA-1) antagonists for the treatment T-cell mediated inflammatory diseases. The company was founded by Thomas Gadek and John P. Burnier in 2006 and is headquartered in Brisbane, CA. | Chief Executive Officer | 01.04.2013 |
Alta Partners Management Co. LP
 Alta Partners Management Co. LP Investment ManagersFinance Alta Partners Management Co. LP (Alta Partners) is a venture capital firm founded in 1996 by Jean Deleage, Guy Paul Nohra, Marino Polestra and Garrett P. Gruener. The firm is headquartered in Jackson, Wyoming. | Director/Board Member | 01.03.2013 |
| TL Ventures LP | Corporate Officer/Principal | 01.02.2006 |
Ausbildung von Robert Alexander
| Miami University | Undergraduate Degree |
| The University of North Carolina at Asheville | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| ALLAKOS INC. | Health Technology |
| ALLENA PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 9 |
|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Alta Partners Management Co. LP
Alta Partners Management Co. LP Investment ManagersFinance Alta Partners Management Co. LP (Alta Partners) is a venture capital firm founded in 1996 by Jean Deleage, Guy Paul Nohra, Marino Polestra and Garrett P. Gruener. The firm is headquartered in Jackson, Wyoming. | Finance |
MPM BioEquities Adviser LLC
 MPM BioEquities Adviser LLC Investment ManagersFinance Founded in 1997 by Ansbert Gadicke and Luke Evnin, MPM BioEquities Adviser LLC is a hedge fund manager located in South San Francisco, California with an additional office in Boston. The firm is a subsidiary of MPM Capital LP, a private equity firm. | Finance |
SARcode Bioscience, Inc.
SARcode Bioscience, Inc. Pharmaceuticals: MajorHealth Technology SARcode Bioscience, Inc., develops biopharmaceutical products. Its program is a novel class of lymphocyte function-associated antigen-1 (LFA-1) antagonists for the treatment T-cell mediated inflammatory diseases. The company was founded by Thomas Gadek and John P. Burnier in 2006 and is headquartered in Brisbane, CA. | Health Technology |
ZS Pharma, Inc.
 ZS Pharma, Inc. Pharmaceuticals: MajorHealth Technology ZS Pharma, Inc. engages in the development of development and commercialization of non-absorbed drugs to treat renal, cardiovascular, liver and metabolic diseases. It develops treatment of hyperkalemia. It also focuses on clinical development, novel technology, and clinical trials. The company was founded by Alvaro F. Guillem and Donald Jeffrey Keyser on February 5, 2008 and is headquartered in San Mateo, CA. | Health Technology |
Lumena Pharmaceuticals, Inc.
 Lumena Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Lumena Pharmaceuticals, Inc. developed oral therapeutics for rare liver diseases. The firm was engaged in the development and commercialization of novel products for rare cholestatic liver diseases and serious metabolic disorders, such as nonalcoholic steatohepatitis. The company was founded by Bronislava Gedulin and Michael G. Grey in January 2011 and was headquartered in San Diego, CA. | Health Technology |
| TL Ventures LP | |
MPM BioImpact, Inc
 MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts. | Finance |
Sonexa Therapeutics, Inc.
 Sonexa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Sonexa Therapeutics, Inc. developed drug treatments for Alzheimer's disease (AD) and related disorders. Its lead compound, ST101 had demonstrated both the cognitive benefits of currently marketed AD treatments along with significant disease modifying effects. The company was founded in January 2008 and was headquartered in San Diego, CA. | Health Technology |
